SMTL ID : 7qk4.1

EED in complex with PRC2 allosteric inhibitor compound 22 (MAK683)

Coordinates
PDB Format
Method
X-RAY DIFFRACTION 1.60 Å
Oligo State
hetero-1-1-mer
Ligands
3 x CL: CHLORIDE ION(Non-functional Binders)
1 x EJR: N-[(5-fluoranyl-2,3-dihydro-1-benzofuran-4-yl)methyl]-8-(2-methylpyridin-3-yl)-[1,2,4]triazolo[4,3-c]pyrimidin-5-amine(Non-covalent)
Links
RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP
Citation
Huang, Y. et al., Discovery of the Clinical Candidate MAK683: An EED-Directed, Allosteric, and Selective PRC2 Inhibitor for the Treatment of Advanced Malignancies. J.Med.Chem. (2022)
Release Date
2022-04-13
Peptides
Polycomb protein EED: A
Histone-lysine N-methyltransferase EZH2: B
SMTL:PDB
SMTL Chain Id:
PDB Chain Id:
A
A
B
B

Polycomb protein EED

Histone-lysine N-methyltransferase EZH2

Related Entries With Identical Sequence

5gsa.1 | 5gsa.2 | 5h14.1 | 5h14.2 | 5h15.1 | 5h15.2 | 5h17.1 | 5h19.1 | 5h24.1 | 5h24.2 | 5h25.1 | 5h25.2 | 6lo2.1 | 6lo2.2 | 7qjg.1 | 7qjg.2 | 7qju.1 | 7qju.2